Praziquantel是一种驱虫药,有效作用于扁形虫。
Praziquantel is an anthelmintic effective against flatworms.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Dan Zhang et. Al. Journal of Neuroscience, 31(44), 15983-15995 (2011).
[2] Phedias Diamandis et. Al. Nature Chemical Biology, 3(5), 268-273 (2007).
[3] R M Greenberg. Parasitology, 131 Suppl, S97-108 (2005).
分子式 C19H24N2O2 |
分子量 312.41 |
CAS号 55268-74-1 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 63 mg/mL |
Water <1 mg/mL |
Ethanol 63 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated | |
NCT01288872 | Schistosomiasis [Bilharziasis] | Drug: Praziquantel | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | 2012-01-01 | 2013-09-26 | |
NCT02868385 | Schistosomiasis | Drug: 5x Praziquantel|Drug: 1x Praziquantel | Leiden University Medical Center|Swiss Tropical & Public Health Institute|Centre Suisse de Recherches Scientifiques en C么te d'Ivoire | Phase 4 | 2017-01-01 | 2016-08-11 | |
NCT00403611 | Schistosomiasis Mansoni | Drug: Praziquantel 60 mg/kg|Drug: Praziquantel 40 mg/kg | Oswaldo Cruz Foundation|World Health Organization|Universidade Federal de Pernambuco | Phase 4 | 2006-03-01 | 2015-06-16 | |
NCT01558336 | Schistosomiasis | Drug: praziquantel | University of Khartoum|Hikma Pharmaceuticals LLC | Phase 3 | 2008-08-01 | 2013-01-16 | |
NCT01054651 | Schistosoma Mansoni | Drug: Artesunate+Sulfamethoxypyrazine/pyrimethamine|Drug: Praziquantel | Kenya Medical Research Institute|Dafra Pharma | Phase 3 | 2009-10-01 | 2010-01-21 | |
NCT01529710 | Schistosoma Hematobium Infection|Schistosomiasis Mansoni | Drug: Myrrh | Pharco Pharmaceuticals | Phase 3 | 2011-12-01 | 2015-02-19 | |
NCT00441285 | Neurocysticercosis|Epilepsy | Drug: Praziquantel|Drug: Albendazole|Drug: ABZ Placebo|Drug: PZQ Placebo | Universidad Peruana Cayetano Heredia|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2|Phase 3 | 2010-01-01 | 2015-05-15 | |
NCT00215267 | Schistosomiasis|Malaria | Drug: praziquantel | DBL -Institute for Health Research and Development|Ministry of Health, Uganda | 2005-09-01 | 2008-02-19 | ||
NCT01541631 | Anemia|Intestinal Helminthiasis|Intestinal Schistosomiasis|Human Immunodeficiency Virus I Infection|Hematologic Diseases|Opportunistic Infections | Drug: Praziquantel and Albendazole|Drug: Praziquantel and Albendazole|Drug: Praziquantel and Albendazole | Catholic University of Health and Allied Sciences|National Institute for Medical Research, Tanzania|University of Cambridge | 2012-05-01 | 2012-03-02 | ||
NCT02325713 | Healthy | Drug: Oral dispersible tablet of praziquantel (ODT-PZQ)|Drug: Cysticide|Drug: ODT-PZQ|Drug: ODT-PZQ|Drug: ODT-PZQ|Drug: Cysticide | Merck KGaA | Phase 1 | 2015-01-01 | 2017-01-03 | |
NCT01901484 | Intestinal Schistosomiasis | Drug: Praziquantel | Makerere University|University of Copenhagen | Phase 2 | 2012-12-01 | 2014-09-16 | |
NCT02734186 | Schistosomiasis | Drug: Praziquantel | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 4 | 2016-03-14 | 2017-03-10 | |
NCT00510159 | Schistosoma Haematobium | Drug: Artesunate+Sulfamethoxypyrazine/pyrimethamin|Drug: Praziquantel | Dafra Pharma | Phase 2|Phase 3 | 2007-08-01 | 2008-01-17 | |
NCT02947581 | Neurocysticercosis | Drug: Albendazole and praziquantel|Drug: Albendazole and praziquantel placebo | Universidad Peruana Cayetano Heredia | Phase 3 | 2016-11-01 | 2016-10-25 | |
NCT00001205 | Cysticercosis | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | 1985-07-22 | 2017-01-24 | |||
NCT02806232 | Schistosomiasis | Drug: Biltricide (racemate praziquantel) oral tablets|Drug: Racemate Praziquantel ODT|Drug: Levo Praziquantel ODT | Merck KGaA | Phase 2 | 2016-06-01 | 2017-01-03 | |
NCT02878564 | Schistosomiasis Mansoni|HIV | Drug: Praziquantel | University of Toronto|UVRI-IAVI HIV Vaccine Program, Uganda | Phase 4 | 2016-03-01 | 2016-10-26 | |
NCT01260012 | Schistosomiasis|Liver Fibrosis|Periportal Fibrosis|Oxidative Stress | Dietary Supplement: Praziquantel+antioxidant suppl|Other: Praziquantel + placebo 2mths then antioxidant for 10 mths|Dietary Supplement: Praziquantel therapy and placebo as supplement|Dietary Supplement: Praziquantel+antioxidant | Addis Ababa University|Ullevaal University Hospital|University of Oslo|University of Agder|Sorlandet Hospital HF | 2010-01-01 | 2010-12-14 | ||
NCT01050374 | Parasitic Diseases | Drug: albendazole + praziquantel|Drug: mebendazole + praziquantel | DBL -Institute for Health Research and Development | 2007-10-01 | 2010-01-14 | ||
NCT01154907 | Uro-genital Schistosomiasis | Drug: praziquantel | Oslo University Hospital|University of KwaZulu|University of Agder|Sorlandet Hospital HF|University of Copenhagen|Leiden University Medical Center|Universiteit Antwerpen | 2010-04-01 | 2016-09-26 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们